Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.001 | 0.007 | 0.007 |
Brugia malayi | Prion-like- | 0.001 | 0.007 | 0.0124 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Echinococcus granulosus | peroxidasin | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | cell adhesion molecule | 0.0013 | 0.3237 | 0.4787 |
Echinococcus granulosus | hemicentin 1 | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | roundabout 2 | 0.002 | 1 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.001 | 0.007 | 0.007 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | receptor tyrosine phosphatase type r2a | 0.001 | 0.007 | 0.0103 |
Schistosoma mansoni | neurotracting/lsamp/neurotrimin/obcam related cell adhesion molecule | 0.001 | 0.007 | 0.0103 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | nephrin | 0.001 | 0.007 | 0.0103 |
Schistosoma mansoni | roundabout | 0.001 | 0.007 | 0.0103 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.3237 | 0.3237 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0013 | 0.3237 | 0.3237 |
Echinococcus multilocularis | neurotracting:lsamp:neurotrimin:obcam | 0.001 | 0.007 | 0.007 |
Echinococcus granulosus | roundabout 2 | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | tyrosine protein kinase otk | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.001 | 0.007 | 0.007 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Echinococcus multilocularis | contactin neuroglian septate junction protein | 0.001 | 0.007 | 0.007 |
Echinococcus granulosus | tyrosine protein kinase otk | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Echinococcus granulosus | neuroglian | 0.0017 | 0.6763 | 0.6763 |
Echinococcus multilocularis | neuroglian | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | peroxidasin | 0.001 | 0.007 | 0.007 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase F | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | hemicentin 1 | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | titin | 0.001 | 0.007 | 0.0103 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0015 | 0.5643 | 1 |
Echinococcus multilocularis | roundabout 2 | 0.001 | 0.007 | 0.007 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Echinococcus multilocularis | hemicentin 1 | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0015 | 0.5643 | 0.5643 |
Echinococcus granulosus | contactin | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | roundabout 2 | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | cell adhesion molecule | 0.001 | 0.007 | 0.0103 |
Echinococcus granulosus | roundabout 2 | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Echinococcus multilocularis | neuroglian | 0.0017 | 0.6763 | 0.6763 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | tyrosine kinase | 0.0012 | 0.2476 | 0.3661 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Schistosoma mansoni | nephrin | 0.0017 | 0.6763 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | neuroglian | 0.001 | 0.007 | 0.0103 |
Echinococcus granulosus | lachesin | 0.001 | 0.007 | 0.007 |
Echinococcus granulosus | twitchin | 0.0017 | 0.6763 | 0.6763 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | cell adhesion molecule | 0.001 | 0.007 | 0.0103 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Echinococcus granulosus | neuroglian | 0.001 | 0.007 | 0.007 |
Schistosoma mansoni | septate junction protein | 0.001 | 0.007 | 0.0103 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.001 | 0.007 | 0.0124 |
Schistosoma mansoni | septate junction protein | 0.001 | 0.007 | 0.0103 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 1 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.001 | 0.007 | 0.0103 |
Onchocerca volvulus | Basement membrane proteoglycan homolog | 0.001 | 0.007 | 0.5 |
Brugia malayi | Peroxidasin | 0.001 | 0.007 | 0.0124 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 1 | 1 |
Echinococcus multilocularis | lachesin | 0.001 | 0.007 | 0.007 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.007 | 0.007 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 175.7 uM | Inhibitory potency of the compound for the protein tyrosine phosphatase(PTP 1B)-catalyzed hydrolysis of p-nitrophenol phosphate | ChEMBL. | 10098656 |
IC50 (functional) | = 175.7 uM | Inhibitory potency of the compound for the protein tyrosine phosphatase(PTP 1B)-catalyzed hydrolysis of p-nitrophenol phosphate | ChEMBL. | 10098656 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.